Public Joint-Stock Company "Pharmsynthez" LIFE.ME Stock
Public Joint-Stock Company "Pharmsynthez" Price Chart
Public Joint-Stock Company "Pharmsynthez" LIFE.ME Financial and Trading Overview
Contents
- Public Joint-Stock Company "Pharmsynthez" Price Chart
- Public Joint-Stock Company "Pharmsynthez" LIFE.ME Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Public Joint-Stock Company "Pharmsynthez"
- Q&A For Public Joint-Stock Company "Pharmsynthez" Stock
| Public Joint-Stock Company "Pharmsynthez" stock price | 4.51 RUB |
| Previous Close | 4.09 RUB |
| Open | 4.21 RUB |
| Bid | 4.51 RUB x 10000 |
| Ask | 4.46 RUB x 10000 |
| Day's Range | 4.2 - 4.9 RUB |
| 52 Week Range | 3.91 - 4.9 RUB |
| Volume | 27.53M RUB |
| Avg. Volume | 0 RUB |
| Market Cap | 1.36B RUB |
| Beta (5Y Monthly) | 0.052054 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.32 RUB |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
LIFE.ME Valuation Measures
| Enterprise Value | 1.96B RUB |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.195145 |
| Price/Book (mrq) | 3.934498 |
| Enterprise Value/Revenue | 4.609 |
| Enterprise Value/EBITDA | 131.589 |
Trading Information
Public Joint-Stock Company "Pharmsynthez" Stock Price History
| Beta (5Y Monthly) | 0.052054 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.9 RUB |
| 52 Week Low | 3.91 RUB |
| 50-Day Moving Average | 3.91 RUB |
| 200-Day Moving Average | 3.91 RUB |
LIFE.ME Share Statistics
| Avg. Volume (3 month) | 0 RUB |
| Avg. Daily Volume (10-Days) | 0 RUB |
| Shares Outstanding | 301.01M |
| Float | 147.22M |
| Short Ratio | N/A |
| % Held by Insiders | 36.16% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | June 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | -120.77% |
| Operating Margin (ttm) | -3.011% |
| Gross Margin | 26.10% |
| EBITDA Margin | 3.50% |
Management Effectiveness
| Return on Assets (ttm) | -0.49% |
| Return on Equity (ttm) | -93.90% |
Income Statement
| Revenue (ttm) | 424.41M RUB |
| Revenue Per Share (ttm) | 1.4 RUB |
| Quarterly Revenue Growth (yoy) | -6.29% |
| Gross Profit (ttm) | 157.39M RUB |
| EBITDA | 14.87M RUB |
| Net Income Avi to Common (ttm) | -512593984 RUB |
| Diluted EPS (ttm) | -2.32 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.48M RUB |
| Total Cash Per Share (mrq) | 0.008 RUB |
| Total Debt (mrq) | 602.63M RUB |
| Total Debt/Equity (mrq) | 174.82 RUB |
| Current Ratio (mrq) | 0.25 |
| Book Value Per Share (mrq) | 1.145 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -58510000 RUB |
| Levered Free Cash Flow (ttm) | -1192375 RUB |
Profile of Public Joint-Stock Company "Pharmsynthez"
| Country | Russia |
| State | N/A |
| City | Saint Petersburg |
| Address | 25 Krasnovo Kursanta Str |
| ZIP | 197110 |
| Phone | 7 812 329 8080 |
| Website | https://www.pharmsynthez.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Public Joint-Stock Company Pharmsynthez', a pharmaceutical company, researches, manufactures, and distributes officinal and generic active pharmaceutical ingredients in Russia and CIS countries. The company offers officinal medicines, including Neovir, Segidrin, Fenasid, and Penkrofton that are used in oncology, gynecology, treatment of immune deficiencies, and tuberculosis. Public Joint-Stock Company Pharmsynthez' has partnership with HiFiBiO Therapeutics Inks for the clinical development and commercialization of its SARS-CoV-2 neutralizing antibody in Russia. Public Joint-Stock Company Pharmsynthez' was founded in 1996 and is based in St. Petersburg, Russia.
Q&A For Public Joint-Stock Company "Pharmsynthez" Stock
What is a current LIFE.ME stock price?
Public Joint-Stock Company "Pharmsynthez" LIFE.ME stock price today per share is 4.51 RUB.
How to purchase Public Joint-Stock Company "Pharmsynthez" stock?
You can buy LIFE.ME shares on the MCX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Public Joint-Stock Company "Pharmsynthez"?
The stock symbol or ticker of Public Joint-Stock Company "Pharmsynthez" is LIFE.ME.
Which industry does the Public Joint-Stock Company "Pharmsynthez" company belong to?
The Public Joint-Stock Company "Pharmsynthez" industry is Biotechnology.
How many shares does Public Joint-Stock Company "Pharmsynthez" have in circulation?
The max supply of Public Joint-Stock Company "Pharmsynthez" shares is 301.01M.
What is Public Joint-Stock Company "Pharmsynthez" Price to Earnings Ratio (PE Ratio)?
Public Joint-Stock Company "Pharmsynthez" PE Ratio is now.
What was Public Joint-Stock Company "Pharmsynthez" earnings per share over the trailing 12 months (TTM)?
Public Joint-Stock Company "Pharmsynthez" EPS is -2.32 RUB over the trailing 12 months.
Which sector does the Public Joint-Stock Company "Pharmsynthez" company belong to?
The Public Joint-Stock Company "Pharmsynthez" sector is Healthcare.
Stocks Related By Sector
Stocks Related By Marketcap
- Lipetsk Power Sale Company Open Joint-Stock Company LPSB.ME Stock
- Volgogradenergosbyt Public Joint-Stock Company VGSB.ME Stock
- Volgogradenergosbyt Public Joint-Stock Company VGSBP.ME Stock
- public-stock company Tomsk distribution company TORSP.ME Stock
- public-stock company Tomsk distribution company TORS.ME Stock